Innogen Pharma and Unit Invest 125 Million Yuan in Bank of Ningbo Structured Products; Shares Slip 2%

MT Newswires Live

2025/12/02

Guangzhou Innogen Pharmaceutical (HKG:2591) and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo (SHE:002142), according to a Monday Hong Kong bourse filing.

Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.

The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.

The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.

Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2588086329"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2588086329\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2588086329?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 12:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588086329","market":"nz","top_or_hot":-1,"title":"Innogen Pharma and Unit Invest 125 Million Yuan in Bank of Ningbo Structured Products; Shares Slip 2%","media":"MT Newswires Live","content":"<html><body><p> Guangzhou Innogen Pharmaceutical (HKG:2591) and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo (SHE:002142), according to a Monday Hong Kong bourse filing.</p><p>Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.</p><p>The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.</p><p>The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.</p><p>Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Innogen Pharma and Unit Invest 125 Million Yuan in Bank of Ningbo Structured Products; Shares Slip 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnogen Pharma and Unit Invest 125 Million Yuan in Bank of Ningbo Structured Products; Shares Slip 2%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-12-02 12:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Guangzhou Innogen Pharmaceutical (HKG:2591) and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo (SHE:002142), according to a Monday Hong Kong bourse filing.</p><p>Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.</p><p>The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.</p><p>The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.</p><p>Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2097828631.EUR","symbol_name":"AZ EQUITY CHINA \"A\" (EUR) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2588086329","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588086329","pubTimestamp":1764648224,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Guangzhou Innogen Pharmaceutical  and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo , according to a Monday Hong Kong bourse filing.Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","BK0278":"货币金融","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","LU2580892862.HKD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (HKD) ACC","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU1146622755.USD":"安本中国A股股票基金A Acc","SGXZ81163826.USD":"UNITED CHINA A-SHARES INNOVATION \"A\" (USD) ACC","SGXZ49509284.SGD":"United China A Shares Innovation A Acc SGD","LU0140636845.USD":"施罗德大中华区股票A Acc","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","02591":"银诺医药-B","BK0183":"MSCI概念","BK0188":"融资融券","BK0187":"一线龙头","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","BK0028":"国家队","002142":"宁波银行","BK0197":"中小创蓝筹","BK0201":"可转债","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","BK1161":"生物科技","LU1688375341.USD":"贝莱德中国灵活股票基金","KTH":"Corts Trust Peco Energy Capital Trust III","LU1720050803.USD":"安联全方位中国股票基金","LU2580892789.USD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (USD) ACC","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC"},"translate_title":"Innogen Pharma和Unit投资宁波银行结构性产品1.25亿元；股价下跌2%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KTH":1.5,"02591":1,"002142":0.9},"content_text":"Guangzhou Innogen Pharmaceutical (HKG:2591) and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo (SHE:002142), according to a Monday Hong Kong bourse filing.Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}